Dementia diagnoses up in individuals with acute kidney injury
By
Haymarket Media
Sep 05, 2024
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Dementia diagnoses drop, but early-onset disease may be increasing among some
By
Kimberly Bonvissuto
Sep 03, 2024
Two separate studies looking at dementia rates found a drop in diagnoses over time due to higher education and decreased smoking levels but an increase in potential early-onset dementia in Native populations.
Regional variation seen in Alzheimer’s and related dementia diagnosis
Aug 19, 2024
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
HbA1c stability tied to lower risk for Alzheimer disease and related dementias
Aug 08, 2024
The findings were seen in a large study of older veterans with diabetes.
Government support of dementia caregiving across the continuum important: poll
By
Kimberly Bonvissuto
Aug 06, 2024
A recent poll of more than 1,000 older adults found they overwhelmingly want the government to support dementia care across the care continuum, including in assisted living settings.
Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.